Speaker illustration

Doctor Jonas Muentze

University Hospital Wuerzburg, Wuerzburg (Germany)

Magnetic resonance imaging of Fabry disease cardiomyopathy in patients receiving oral chaperone therapy

Event: ESC Congress 2019

Topic: Cardiac Masses

Session: Multimodality imaging in cardiomyopathy


Treatment of cardiac manifestations in Fabry disease with the oral drug Migalastat: First 12 months results from a cohort of amenable all-comers

Event: ESC Congress 2018

Topic: Infiltrative Myocardial Disease

Session: Cardiomyopathy in Fabry disease


Treatment of Fabry disease with a new oral drug: Initial real-world single-center experience

Event: ESC Congress 2017

Topic: Cardiomyopathies

Session: Cardiomyopathy in Fabry disease


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb